A Case of Mixed Connective Tissue Disease Associated with Graves' Disease

M. Erkan Kozanoğlu, İlke Coşkun Benlidayı, Murat Sert

Issue: Volume 23 - Issue 3 - June 2008
1000 6672

Retroperitoneal Fibrosis and Aortitis as the Initial Findings of Systemic Lupus Erythematosus

Aynur SOYUÖZ, Metin IŞIK, İsmail DOĞAN, Levent KILIÇ, Sedat KİRAZ

DOI: 10.5606/tjr.2011.042

Issue: Volume 26 - Issue 3 - September 2011
9060 6388

Serum Interleukin-18 Level is Associated With Disease Activity and Interstitial Lung Disease in Patients With Dermatomyositis

Yuan YANG, Geng YIN, Jingcheng HAO, Qibing XIE, Yi LIU

DOI: 10.5606/ArchRheumatol.2017.6175

Issue: Volume 32 - Issue 3 - September 2017
6702 4994

The Association of Anti-Aminoacyl-Transfer Ribonucleic Acid Synthetase Antibodies in Patients With Rheumatoid Arthritis and Interstitial Lung Disease

Masakazu MATSUSHITA, Naoto TAMURA, Michihiro OGASAWARA, Kurisu TADA, Ken YAMAJI, Yoshinari TAKASAKI

DOI: 10.5606/ArchRheumatol.2018.6401

Issue: Volume 33 - Issue 1 - March 2018
4927 6064

Value of Serum Carbohydrate Antigen 19-9 and Carcinoembryonic Antigen in Evaluating Severity and Prognosis of Connective Tissue Disease-Associated Interstitial Lung Disease

Qian JIN, Jisheng ZHENG, Xianrong XU, Yeming HU, Ying ZHOU, Weihua XU, Feihua HUANG

DOI: 10.5606/ArchRheumatol.2018.6419

Issue: Volume 33 - Issue 2 - June 2018
4677 5022

Recurrent Benign Pneumatosis Intestinalis in a Patient With Mixed Connective Tissue Disease

Sahil KOPPIKAR, David YU, Mark ROPELESKI, David ROBERTSON

DOI: 10.5606/ArchRheumatol.2018.6589

Issue: Volume 33 - Issue 4 - December 2018
2721 4151

Clinical Characteristics of Systemic Sclerosis With Interstitial Lung Disease

Eunju JUNG, Chang-hee SUH, Hyoun-ah KİM, Ju-yang JUNG

DOI: 10.5606/ArchRheumatol.2018.6630

Issue: Volume 33 - Issue 3 - September 2018
4466 5062

Tumor-Associated Antigens in Rheumatoid Arthritis Interstitial Lung Disease or Malignancy?

Gökhan SARGIN, Reyhan KÖSE, Taşkın ŞENTÜRK

DOI: 10.5606/ArchRheumatol.2018.6691

Issue: Volume 33 - Issue 4 - December 2018
3212 6750

Efficacy of Combination Therapy With Pirfenidone and Low-Dose Cyclophosphamide for Refractory Interstitial Lung Disease Associated With Connective Tissue Disease: A Case-Series of Seven Patients

Lichong SHEN, Qingran YAN, Xiaoxiang CHEN

DOI: 10.46497/ArchRheumatol.2020.7381

Issue: Volume 35 - Issue 2 - June 2020
2977 3423

Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus

Yaling CHEN, Yanqing WANG, Xiangfang CHEN, Huishun LIANG, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2020.7583

Issue: Volume 35 - Issue 2 - June 2020
2976 1943

Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases

Andreina MANFREDI, Giulia CASSONE, Caterina VACCHI, Fabrizio PANCALDI, Giovanni Della CASA, Stefania CERRI, Lisa De PASQUALE, Fabrizio LUPPI, Carlo SALVARANI, Marco SEBASTIANI

DOI: 10.46497/ArchRheumatol.2021.7975

Issue: Volume 36 - Issue 1 - March 2021
3342 2083

Clinical and serological characteristics of systemic sclerosis: Experience of a tertiary care center in Pakistan

Sadia Asif, Asadullah Khan, Muhammad Faiq, Zia Ud Din, Sarmad Zahoor, Muhammad Haroon

DOI: 10.46497/ArchRheumatol.2021.8701

Issue: Volume 36 - Issue 4 - December 2021
1533 1781

The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis

Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur

DOI: 10.46497/ArchRheumatol.2023.9636

Issue: Volume 38 - Issue 2 - June 2023
1133 1036

Progressive pulmonary fibrosis in patients with connective tissue disease-associated interstitial lung disease: An explorative study

Jakob Höppner, Maximilian Wollsching-Strobel, Falk Schumacher, Wolfram Windisch, Melanie Berger

DOI: 10.46497/ArchRheumatol.2024.10105

Issue: Volume 39 - Issue 1 - March 2024
902 829

Predictive risk factors for one-year mortality in idiopathic inflammatory myopathy patients with interstitial lung disease: A retrospective, single-center cohort study

Minna Jiang, Xiaohong Wen, Sisi Xia, Yiqun Guo, Yu Bai

DOI: 10.46497/ArchRheumatol.2024.10418

Issue: Volume 39 - Issue 2 - June 2024
634 527

Rituximab for rheumatoid arthritis-related interstitial lung disease: A systematic review and meta-analysis

Tarun Krishna Boppana, Saurabh Mittal, Karan Madan, Anant Mohan, Vijay Hadda, Randeep Guleria

DOI: 10.46497/ArchRheumatol.2024.10199

Issue: Volume 39 - Issue 2 - June 2024
1529 1140